Treatment of Recurrent Focal Segmental Glomerulosclerosis in Pediatric Kidney Transplant Recipients: Effect of Rituximab

Recurrence of focal segmental glomerulosclerosis (FSGS) after renal transplantation is a complication that often leads to graft loss. There is no consensus on the optimal treatment of recurrent FSGS. Rituximab, a monoclonal antibody to CD20, may be a useful treatment of this complication. Methods. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethna, Christine, Benchimol, Corinne, Hotchkiss, Hilary, Frank, Rachel, Infante, Lulette, Vento, Suzanne, Trachtman, Howard
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090748/
https://www.ncbi.nlm.nih.gov/pubmed/21577271
http://dx.doi.org/10.1155/2011/389542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090748/
https://www.ncbi.nlm.nih.gov/pubmed/21577271
http://dx.doi.org/10.1155/2011/389542

Ejemplares similares